一项队列研究揭示接种Comirnaty和Vaxzevria疫苗后SARS-CoV-2特异性抗体形成的不同动态
该队列研究纳入1395名受试者,在接种前、第一剂后和第二剂后三个时间点检测抗RBD IgG抗体水平,采用广义加性模型分析性别、年龄、疫苗类型(Comirnaty或Vaxzevria)及接种后时间对抗体产生动态的影响。结果显示两种疫苗抗体产生动态存在变异性,男女抗体水平无显著差异,年龄与抗体产生呈非线性关系,30岁及以下和60岁以上人群抗体水平降低,中年段无相关性。
要点
- 两种疫苗(Comirnaty和Vaxzevria)抗体产生动态存在变异性。
- 男女之间抗体水平无显著差异。
- 年龄与抗体产生呈非线性关系,30岁及以下和60岁以上抗体水平降低。
核心结论
- 研究结果增进了对疫苗诱导免疫机制的理解,并提出广义加性模型可作为类似研究数据呈现的标准化方法。
研究设计与样本
- 队列研究,共纳入1395名受试者,在接种前、第一剂后和第二剂后三个时间点检测血清抗RBD IgG抗体水平。
主要发现
- 两种疫苗(Comirnaty和Vaxzevria)的抗体产生动态存在变异性。
- 男女之间未发现抗体水平的明显差异。
- 年龄与抗体产生呈非线性关系,30岁及以下和60岁以上人群抗体水平降低,中年段无相关性。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The Coronavirus (COVID-19) Disease Pandemic, caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), has affected millions of people worldwide, prompting a collective effort from the global scientific community to develop a vaccine against it. This study purports to investigate the influence of factors such as sex, age, type of vaccination (Comirnaty, BNT162b2, Pfizer Inc. or Vaxzevria, ChAdOx1-S, Oxford/AstraZeneca), and time since vaccine administration on the process of antibody production. Both of them are based on the introduction of SARS-CoV-2 spike protein (S protein) to the body using different mechanisms (mRNA and recombinant adenovirus, respectively). S protein is responsible for host cell attachment and penetration via its receptor-binding domain (RBD domain). The level of anti-RBD IgG antibodies was tested with an ELISA-based immunodiagnostic assay in serum samples from a total of 1395 patients at 3 time points: before vaccination, after the first dose, and after the second dose. Our novel statistical model, the Generalized Additive Model, revealed variability in antibody production dynamics for both vaccines. Interestingly, no discernible variation in antibody levels between men and women was found. A nonlinear relationship between age and antibody production was observed, characterized by decreased antibody levels for people up to 30 and over 60 years of age, with a lack of correlation in the middle age range. Collectively, our findings further the understanding of the mechanism driving vaccine-induced immunity. Additionally, we propose the Generalized Additive Model as a standardized way of presenting data in similar research.
引用
- Augustyniak A, Szymański T, Porzucek F, et al. A cohort study reveals different dynamics of SARS-CoV-2-specific antibody formation after Comirnaty and Vaxzevria vaccination. Vaccine. 2023. PMID: 37407407. doi:10.1016/j.vaccine.2023.06.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。